About Merieux Equity Partners
Merieux Equity Partners is a Financial Services company based in Lyon (France). Pivate equity firm that focuses on investing in healthcare and nutrition companies. It operates on a B2B model. Merieux Equity Partners has completed 7 acquisitions, including Curea medical, Doc Generici and InnoSyn. Its focus areas include Investment Industry, Private Equity Funds and Buyout Funds.
Company details
Merieux Equity Partners is headquartered in Lyon, France, where operations as a private equity firm are conducted. Focus is placed on healthcare and nutrition sectors, with investments directed toward biotech, diagnostics, and related sub-sectors. High-potential companies are supported through capital provision and operational guidance to facilitate development and expansion across Europe and beyond.
- Headquarters Lyon, France
- SectorsFinancial Services
- Website merieux-partners.com
- Investments & AcquisitionsCurea medical
& 6 more
People of Merieux Equity Partners
11 people are tracked at Merieux Equity Partners (4 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Jean Chatillon | Director Of Investor Relations And Communication | Leadership |
Emna Bourkhis | Director | Leadership |
Theodor Wuppermann | Partner | Leadership |
Quentin de Labarre | Managing Director | Leadership |
Jonathan Dupont | Associate | Team |
Leo Reimann | Private Equity Analyst | Team |
Guillaume Thoviste | Associate - Life Sciences | Team |
Marion Gartner | RCCI - Responsable Conformité & Contrôle Interne | Team |
Florent Rosset | Accounting & Treasury Manager | Team |
Bertrand Rambaud | Membre Du Comité D'investissement | Team |
Andrea Ottavis | Venture Capital Analyst | Team |
Complete people profiles for Merieux Equity Partners
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Merieux Equity Partners
Merieux Equity Partners has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Curea medical, Doc Generici and InnoSyn.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Wound dressing solutions are developed using supercore technology. | curea-medical.de | Steinfurt, Germany | 2010 | Mar 2025 | •••• | |
Provides research and development of chemical processes | innosyn.com | Geleen, Netherlands | 2017 | Feb 2024 | •••• | |
Quality services are provided for healthcare, pharmaceutical, and medical industries. | labquality.com | Helsinki, Finland | 1971 | Dec 2023 | •••• | |
Plant-based nutraceuticals, dietary supplements, animal nutrition, and cosmetics are manufactured. | plantex.fr | 1990 | Jan 2021 | •••• | ||
Generic pharmaceuticals and ophthalmology products are manufactured in Italy. | docgenerici.it | Milan, Italy | 1996 | Apr 2019 | $5.05B | |
Pharmaceutical drugs are manufactured in Chambery, France. | omnipharm.fr | Chambery, France | 2008 | Jan 2019 | •••• | |
Food supplements are distributed by NUTRAGROUP in the French market. | nutragroup.fr | Chambery, France | 2008 | Jan 2019 | •••• |
Complete acquisition details for Merieux Equity Partners
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Merieux Equity Partners
7 dated milestones of Merieux Equity Partners across 6 years, from founding to its latest funding, stage changes and deals.
- Acquisition Acquires NUTRAGROUP.
- Acquisition Acquires Omnipharm.
- Acquisition Acquires Doc Generici.
- Acquisition Acquires Plantex.
- Acquisition Acquires Labquality.
- Acquisition Acquires InnoSyn.
- Acquisition Acquires Curea medical.
Web traffic of Merieux Equity Partners
Websites that share an audience with Merieux Equity Partners (merieux-partners.com).
Websites whose visitors overlap most with Merieux Equity Partners. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| institut-merieux.com | 100% | 1.7K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Merieux Equity Partners
Complete news archive for Merieux Equity Partners
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Merieux Equity Partners
Merieux Equity Partners is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Merieux Equity Partners is headquartered in Lyon, France, where operations as a private equity firm are conducted. Focus is placed on healthcare and nutrition sectors, with investments directed toward biotech, diagnostics, and related sub-sectors. High-potential companies are supported through capital provision and operational guidance to facilitate development and expansion across Europe and beyond.
Merieux Equity Partners has made 7 acquisitions, including Curea medical, Doc Generici, and InnoSyn.